• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801074
Device Problem Out-Of-Box Failure (2311)
Patient Problem No Patient Involvement (2645)
Event Date 12/14/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Evaluation is in progress, but not yet concluded.The voltage from the o2 sensor with 100% oxygen was 1.340 volts direct current (vdc), which is within specifications.With the blender setpoint at 21%, the central control monitor (ccm) reported 30.5%, which is out of specifications.The external o2 analyzer showed the actual o2 as 20.9%.The srt re-calibrated and received the same results.
 
Event Description
Upon receipt of the device, the service repair technician (srt) reported that the oxygen (o2) sensor failed the reading accuracy portion of the verification test for the electronic patient gas system (epgs).There was no patient involvement.
 
Manufacturer Narrative
Per evaluation, the oxygen (o2) sensor passed voltage but failed o2 reading accuracy (complaint condition was duplicated).The voltage reading was 1.49 volts which was within specification.With the blender setpoint of 21%, the central control monitor (ccm) reading was 26.8% and o2 analyzer reading was 20.8% (out of specification).With the blender setpoint of 30%, the ccm reading was 31.0% and o2 analyzer reading was 25.6% (out of specification).With the blender setpoint of 80%, the ccm and o2 analyzer readings were in acceptable range and met specification.
 
Manufacturer Narrative
The reported complaint was confirmed.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
6200 jackson road
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key5346663
MDR Text Key35558214
Report Number1828100-2016-00002
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K022947
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 03/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/23/2016
Device Model Number801074
Device Catalogue Number801074
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/14/2015
Initial Date FDA Received01/06/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received02/10/2016
03/10/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/24/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-